Mouse Anti-ERCC6L Recombinant Antibody (3F12-2B10) (V2LY-0825-LY676)

Go to compare Compare Online Inquiry
Published Data
Request for COA
Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal
Mouse
Clone
3F12-2B10
Application
ELISA, WB
Immunogen
Full length recombinant ERCC6L.
Host Species
Mouse
Specificity
Human
Antibody Isotype
IgG2a, κ
Clonality
Monoclonal Antibody

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS
Preservative
None
Concentration
Batch dependent
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.
More Infomation

Target

Full Name
ERCC Excision Repair 6 Like, Spindle Assembly Checkpoint Helicase
Entrez Gene ID
UniProt ID
Research Area
DNA helicase that acts as a tension sensor that associates with catenated DNA which is stretched under tension until it is resolved during anaphase (PubMed:17218258, PubMed:23973328).

Functions as ATP-dependent DNA translocase (PubMed:23973328, PubMed:28977671).

Can promote Holliday junction branch migration (in vitro) (PubMed:23973328).
Biological Process
Cell cycle Source: UniProtKB-KW
Cell division Source: UniProtKB-KW
Cellular Location
Centromere; Kinetochore; Chromosome. Localizes to kinetochores, inner centromeres and thin threads connecting separating chromosomes even during anaphase. In prometaphase cells, it mostly concentrates in between kinetochores. In metaphase, it localizes to numerous thin threads that stretch between sister kinetochores of the aligned chromosomes and are composed of catenated centromeric DNA. Evolution from inner centromeres to thin threads takes place in response to tension. Resolution of thin threads requires topoisomerase 2-alpha (TOP2A) after anaphase onset.
PTM
Phosphorylation by PLK1 prevents the association with chromosome arms and restricts its localization to the kinetochore-centromere region.

Huang, X., Jiang, L., Lu, S., Yuan, M., Lin, H., Li, B., ... & Zhong, Y. (2022). Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma. Oncology Reports, 48(1), 1-18.

Hou, G., Lu, Z., Bi, Y., Deng, J., & Yang, X. (2022). ERCC6L is a biomarker and therapeutic target for non–small cell lung adenocarcinoma. Medical Oncology, 39(5), 1-16.

Zhang, G., Yu, Z., Fu, S., Lv, C., Dong, Q., Fu, C., ... & Zeng, Y. (2022). Correction to: ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway. Cancer Gene Therapy, 1-1.

Zhang, G., Ma, J., Xiong, J., Huang, X., Han, X., Yu, X., & Jiang, X. (2021). Upregulation of Excision Repair Cross-Complementation Group 6-Like (ERCC6L) Promotes Tumor Growth in Hepatocellular Carcinoma. Digestive Diseases and Sciences, 66(4), 1097-1109.

Chen, D., Liu, Q., & Cao, G. (2021). ERCC6L promotes cell growth and metastasis in gastric cancer through activating NF-κB signaling. Aging (Albany NY), 13(16), 20218.

Yu, B., Liang, H., Ye, Q., & Wang, Y. (2020). Upregulation of ERCC6L is associated with tumor progression and unfavorable prognosis in hepatocellular carcinoma. Journal of Gastrointestinal Oncology, 11(5), 1009.

Chen, H., Wang, H., Yu, X., Zhou, S., Zhang, Y., Wang, Z., ... & Wang, Z. (2020). ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway. BMC cancer, 20(1), 1-10.

Xie, Y., Yu, J., Wang, F., Li, M., Qiu, X., Liu, Y., & Qi, J. (2019). ERCC6L promotes cell growth and invasion in human colorectal cancer. Oncology letters, 18(1), 237-246.

Zhang, G., Yu, Z., Fu, S., Lv, C., Dong, Q., Fu, C., ... & Zeng, Y. (2019). ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway. Cancer Gene Therapy, 26(9), 323-333.

Liu, J., Sun, J., Zhang, Q., & Zeng, Z. (2018). shRNA knockdown of DNA helicase ERCC6L expression inhibits human breast cancer growth. Molecular Medicine Reports, 18(3), 3490-3496.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-ERCC6L Recombinant Antibody (3F12-2B10)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

online inquiry
Online Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.